Impact of radiation technique upon the outcome of treatment for medulloblastoma-Reference-Cited by-同舟云学术

Impact of radiation technique upon the outcome of treatment for medulloblastoma

Published:1996-08 Issue:1 Volume:36 Page:233-239
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Halperin Edward C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference44 articles.

1. Medulloblastomas: Concerning the problems of spinal metastasis and malignancy: A report of six cases and discussion of the problems involved;Abbott;Bull. LA Neurol. Soc.,1943

2. Medulloblastoma: Freedom from relapse longer than 8 years—A therapeutic cure?;Belza;J. Neurosurg.,1991

3. High-dose areas are unintentionally created as a result of gap shifts when the prescribed dose in the two adjacent areas are different;Bentel;Med. Dosim.,1990

4. Radiation treatment for medulloblastoma: A 21-year review;Berry;J. Neurosurg.,1981

5. A beam alignment device for matching fields;Buck;Int. J. Radiat. Oncol. Biol. Phys.,1985

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of particle therapy in cancer;Cancer Research, Statistics, and Treatment;2023

2. Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation;Advances in Radiation Oncology;2022-09

3. Early Dural Sac Termination with Lumbar Disc Herniation: A Mimic of Nerve Root Anomalies;Journal of Minimally Invasive Spine Surgery and Technique;2020-10-08

4. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis;Pediatric Blood & Cancer;2020-05-26

5. Reduced‐volume tumor‐bed boost is not associated with inferior local control and survival outcomes in high‐risk medulloblastoma;Pediatric Blood & Cancer;2019-10